Brief: Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO
07/01/2026 13:51
Jan 7 (Reuters) - Medical Developments International Ltd MVP.AX: VAXXAS APPOINTS FORMER MERCK GLOBAL VACCINES PRESIDENT DAVID PEACOCK AS CEO Source text: ID:nGNX3hwtkN Further company coverage: MVP.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medical Developments International
See all newsBrief: Medical Developments International Reports Group Revenue For Q1 FY27 Of A$10.2 Million
Brief: Medical Developments International Says CEO Brent MacGregor Intends To Step Down
Australia's Medical Developments International gains on higher annual revenue
Brief: Medical Developments International Logs FY Full Revenue A$42.6 Million
Medical Developments International soars on robust quarterly revenue